"The Supreme Court temporarily paused a lower court ruling that banned health care providers from remotely prescribing and shipping abortion medication by mail, reinstating access to mifepristone until at least May 11."
"The case revolves around a lawsuit brought by Louisiana against the FDA over a Biden administration rule that allowed telehealth practitioners to prescribe mifepristone to patients nationwide, including in states with abortion bans."
"The FDA has declared mifepristone safe, with 36 reports of adverse effects since its approval, though many cases arose from improper use during ectopic pregnancies, and no causal relation can be definitively established."
The Supreme Court paused a lower court ruling that banned remote prescriptions of mifepristone, allowing mail access until May 11. This follows a lawsuit from Louisiana against the FDA regarding telehealth prescriptions. The FDA approved mifepristone for medical abortions in 2000 and 2016, declaring it safe when used correctly. Despite 36 reports of adverse effects, no definitive causal relation has been established. The case is set for further consideration as the FDA reviews regulations, with a deadline of October 7 for completion.
Read at www.scientificamerican.com
Unable to calculate read time
Collection
[
|
...
]